Catálogo de publicaciones - revistas

Compartir en
redes sociales


Nature

Resumen/Descripción – provisto por la editorial en inglés
Nature is a weekly international journal publishing the finest peer-reviewed research in all fields of science and technology on the basis of its originality, importance, interdisciplinary interest, timeliness, accessibility, elegance and surprising conclusions. Nature also provides rapid, authoritative, insightful and arresting news and interpretation of topical and coming trends affecting science, scientists and the wider public.
Palabras clave – provistas por la editorial

No disponibles.

Disponibilidad
Institución detectada Período Navegá Descargá Solicitá
No detectada desde jul. 2012 / hasta dic. 2023 Nature.com
No detectada desde jul. 2006 / hasta ago. 2012 Ovid

Información

Tipo de recurso:

revistas

ISSN impreso

0028-0836

ISSN electrónico

1476-4687

Editor responsable

Springer Nature

País de edición

Reino Unido

Fecha de publicación

Tabla de contenidos

Widespread changes in surface temperature persistence under climate change

Jingyuan Li; David W. J. ThompsonORCID

Palabras clave: Multidisciplinary.

Pp. 425-430

Cardiopharyngeal deconstruction and ancestral tunicate sessility

Alfonso Ferrández-RoldánORCID; Marc Fabregà-TorrusORCID; Gaspar Sánchez-SernaORCID; Enya Duran-BelloORCID; Martí Joaquín-LluísORCID; Paula BujosaORCID; Marcos Plana-CarmonaORCID; Jordi Garcia-FernàndezORCID; Ricard AlbalatORCID; Cristian CañestroORCID

Palabras clave: Multidisciplinary.

Pp. 431-435

MC3R links nutritional state to childhood growth and the timing of puberty

B. Y. H. LamORCID; A. WilliamsonORCID; S. FinerORCID; F. R. DayORCID; J. A. TadrossORCID; A. Gonçalves Soares; K. WadeORCID; P. Sweeney; M. N. Bedenbaugh; D. T. PorterORCID; A. Melvin; K. L. J. Ellacott; R. N. Lippert; S. Buller; J. Rosmaninho-Salgado; G. K. C. Dowsett; K. E. Ridley; Z. Xu; I. CiminoORCID; D. Rimmington; K. Rainbow; K. Duckett; S. HolmqvistORCID; A. KhanORCID; X. Dai; E. G. Bochukova; R. C. Trembath; H. C. MartinORCID; A. P. Coll; D. H. RowitchORCID; N. J. WarehamORCID; D. A. van HeelORCID; N. TimpsonORCID; R. B. SimerlyORCID; K. K. OngORCID; R. D. ConeORCID; C. LangenbergORCID; J. R. B. PerryORCID; G. S. YeoORCID; S. O’RahillyORCID;

Palabras clave: Multidisciplinary.

Pp. 436-441

Linking hippocampal multiplexed tuning, Hebbian plasticity and navigation

Jason J. MooreORCID; Jesse D. Cushman; Lavanya Acharya; Briana Popeney; Mayank R. MehtaORCID

Palabras clave: Multidisciplinary.

Pp. 442-448

The orbitofrontal cortex maps future navigational goals

Raunak BasuORCID; Robert Gebauer; Tim Herfurth; Simon Kolb; Zahra Golipour; Tatjana TchumatchenkoORCID; Hiroshi T. ItoORCID

<jats:title>Abstract</jats:title><jats:p>Accurate navigation to a desired goal requires consecutive estimates of spatial relationships between the current position and future destination throughout the journey. Although neurons in the hippocampal formation can represent the position of an animal as well as its nearby trajectories<jats:sup>1–7</jats:sup>, their role in determining the destination of the animal has been questioned<jats:sup>8,9</jats:sup>. It is, thus, unclear whether the brain can possess a precise estimate of target location during active environmental exploration. Here we describe neurons in the rat orbitofrontal cortex (OFC) that form spatial representations persistently pointing to the subsequent goal destination of an animal throughout navigation. This destination coding emerges before the onset of navigation, without direct sensory access to a distal goal, and even predicts the incorrect destination of an animal at the beginning of an error trial. Goal representations in the OFC are maintained by destination-specific neural ensemble dynamics, and their brief perturbation at the onset of a journey led to a navigational error. These findings suggest that the OFC is part of the internal goal map of the brain, enabling animals to navigate precisely to a chosen destination that is beyond the range of sensory perception.</jats:p>

Palabras clave: Multidisciplinary.

Pp. 449-452

Temporal controls over inter-areal cortical projection neuron fate diversity

Esther Klingler; Ugo Tomasello; Julien PradosORCID; Justus M. Kebschull; Alessandro ContestabileORCID; Gregorio L. Galiñanes; Sabine Fièvre; Antonio Santinha; Randall Platt; Daniel HuberORCID; Alexandre Dayer; Camilla BelloneORCID; Denis JabaudonORCID

Palabras clave: Multidisciplinary.

Pp. 453-457

Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians

Yuko SatoORCID; Koji AtarashiORCID; Damian R. PlichtaORCID; Yasumichi Arai; Satoshi Sasajima; Sean M. Kearney; Wataru Suda; Kozue Takeshita; Takahiro Sasaki; Shoki Okamoto; Ashwin N. SkellyORCID; Yuki Okamura; Hera VlamakisORCID; Youxian Li; Takeshi TanoueORCID; Hajime Takei; Hiroshi Nittono; Seiko Narushima; Junichiro IrieORCID; Hiroshi Itoh; Kyoji Moriya; Yuki Sugiura; Makoto SuematsuORCID; Nobuko Moritoki; Shinsuke ShibataORCID; Dan R. Littman; Michael A. FischbachORCID; Yoshifumi Uwamino; Takashi InoueORCID; Akira HondaORCID; Masahira Hattori; Tsuyoshi Murai; Ramnik J. XavierORCID; Nobuyoshi Hirose; Kenya HondaORCID

Palabras clave: Multidisciplinary.

Pp. 458-464

Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy

Rachel Yamin; Andrew T. JonesORCID; Hans-Heinrich HoffmannORCID; Alexandra Schäfer; Kevin S. Kao; Rebecca L. Francis; Timothy P. SheahanORCID; Ralph S. BaricORCID; Charles M. RiceORCID; Jeffrey V. RavetchORCID; Stylianos BournazosORCID

Palabras clave: Multidisciplinary.

Pp. 465-470

B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity

Baihao Zhang; Alexis Vogelzang; Michio Miyajima; Yuki Sugiura; Yibo Wu; Kenji Chamoto; Rei Nakano; Ryusuke Hatae; Rosemary J. Menzies; Kazuhiro Sonomura; Nozomi Hojo; Taisaku Ogawa; Wakana Kobayashi; Yumi Tsutsui; Sachiko Yamamoto; Mikako Maruya; Seiko Narushima; Keiichiro Suzuki; Hiroshi Sugiya; Kosaku Murakami; Motomu Hashimoto; Hideki Ueno; Takashi Kobayashi; Katsuhiro Ito; Tomoko Hirano; Katsuyuki Shiroguchi; Fumihiko Matsuda; Makoto Suematsu; Tasuku Honjo; Sidonia FagarasanORCID

<jats:title>Abstract</jats:title><jats:p>Small, soluble metabolites not only are essential intermediates in intracellular biochemical processes, but can also influence neighbouring cells when released into the extracellular milieu<jats:sup>1–3</jats:sup>. Here we identify the metabolite and neurotransmitter GABA as a candidate signalling molecule synthesized and secreted by activated B cells and plasma cells. We show that B cell-derived GABA promotes monocyte differentiation into anti-inflammatory macrophages that secrete interleukin-10 and inhibit CD8<jats:sup>+</jats:sup> T cell killer function. In mice, B cell deficiency or B cell-specific inactivation of the GABA-generating enzyme GAD67 enhances anti-tumour responses. Our study reveals that, in addition to cytokines and membrane proteins, small metabolites derived from B-lineage cells have immunoregulatory functions, which may be pharmaceutical targets allowing fine-tuning of immune responses.</jats:p>

Palabras clave: Multidisciplinary.

Pp. 471-476

Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs

Mark Yarmarkovich; Quinlen F. MarshallORCID; John M. Warrington; Rasika Premaratne; Alvin Farrel; David Groff; Wei Li; Moreno di Marco; Erin Runbeck; Hau Truong; Jugmohit S. Toor; Sarvind TripathiORCID; Son NguyenORCID; Helena ShenORCID; Tiffany Noel; Nicole L. Church; Amber Weiner; Nathan KendserskyORCID; Dan Martinez; Rebecca Weisberg; Molly Christie; Laurence Eisenlohr; Kristopher R. Bosse; Dimiter S. DimitrovORCID; Stefan Stevanovic; Nikolaos G. Sgourakis; Ben R. Kiefel; John M. MarisORCID

<jats:title>Abstract</jats:title><jats:p>The majority of oncogenic drivers are intracellular proteins, thus constraining their immunotherapeutic targeting to mutated peptides (neoantigens) presented by individual human leukocyte antigen (HLA) allotypes<jats:sup>1</jats:sup>. However, most cancers have a modest mutational burden that is insufficient to generate responses using neoantigen-based therapies<jats:sup>2,3</jats:sup>. Neuroblastoma is a paediatric cancer that harbours few mutations and is instead driven by epigenetically deregulated transcriptional networks<jats:sup>4</jats:sup>. Here we show that the neuroblastoma immunopeptidome is enriched with peptides derived from proteins that are essential for tumourigenesis and focus on targeting the unmutated peptide QYNPIRTTF, discovered on HLA-A*24:02, which is derived from the neuroblastoma dependency gene and master transcriptional regulator <jats:italic>PHOX2B</jats:italic>. To target QYNPIRTTF, we developed peptide-centric chimeric antigen receptors (CARs) using a counter-panning strategy with predicted potentially cross-reactive peptides. We further hypothesized that peptide-centric CARs could recognize peptides on additional HLA allotypes when presented in a similar manner. Informed by computational modelling, we showed that PHOX2B peptide-centric CARs also recognize QYNPIRTTF presented by HLA-A*23:01 and the highly divergent HLA-B*14:02. Finally, we demonstrated potent and specific killing of neuroblastoma cells expressing these HLAs in vitro and complete tumour regression in mice. These data suggest that peptide-centric CARs have the potential to vastly expand the pool of immunotherapeutic targets to include non-immunogenic intracellular oncoproteins and widen the population of patients who would benefit from such therapy by breaking conventional HLA restriction.</jats:p>

Palabras clave: Multidisciplinary.

Pp. 477-484